Claim Your New User Special: Get your second month free ▶ Second Month Free

Serving leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson
Baxter
Medtronic
McKesson
McKinsey

Last Updated: June 27, 2022

Details for New Drug Application (NDA): 018276


✉ Email this page to a colleague

« Back to Dashboard

NDA 018276 describes XANAX, which is a drug marketed by Upjohn and is included in two NDAs. It is available from eight suppliers. Additional details are available on the XANAX profile page.

The generic ingredient in XANAX is alprazolam. There are fifteen drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the alprazolam profile page.
Summary for 018276
Tradename:XANAX
Applicant:Upjohn
Ingredient:alprazolam
Patents:0
Formulation / Manufacturing:see details
Pharmacology for NDA: 018276
Medical Subject Heading (MeSH) Categories for 018276
Suppliers and Packaging for NDA: 018276
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
XANAX alprazolam TABLET;ORAL 018276 NDA Pharmacia & Upjohn Company LLC 0009-0029 0009-0029-01 100 TABLET in 1 BOTTLE (0009-0029-01)
XANAX alprazolam TABLET;ORAL 018276 NDA Pharmacia & Upjohn Company LLC 0009-0029 0009-0029-02 500 TABLET in 1 BOTTLE (0009-0029-02)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.25MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 002

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength0.5MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Profile for product number 003

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength1MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Expired US Patents for NDA 018276

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Upjohn XANAX alprazolam TABLET;ORAL 018276-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
Upjohn XANAX alprazolam TABLET;ORAL 018276-004 Nov 27, 1985 See Plans and Pricing See Plans and Pricing
Upjohn XANAX alprazolam TABLET;ORAL 018276-002 Approved Prior to Jan 1, 1982 See Plans and Pricing See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
AstraZeneca
Dow
Harvard Business School
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.